Takeda
![Takeda](https://cardiff.imgix.net/__data/assets/image/0008/1279637/DefaultLogo.png?w=873&ar=16:9&q=80&auto=format)
Cardiff University has formed a partnership with Takeda Pharmaceutical Company Limited (Takeda) for a drug discovery collaboration to identify new approaches for treating schizophrenia and other psychiatric disorders.
The collaboration will combine the University's large scale genomic data and world-class expertise in psychiatric genetics, genomics, clinical and basic neuroscience with Takeda’s extensive drug discovery and clinical development capabilities.
The collaboration will allow Takeda access to world-leading biological psychiatry research and the related infrastructure across the University, including the
Enquiries
For more information regarding the Takeda partnership, please contact:
![Professor Lawrence Wilkinson](https://cardiff.imgix.net/__data/assets/image/0006/10869/lawrence-wilkinson.jpg?w=120&h=120&auto=format&crop=faces&fit=crop)
Professor Lawrence Wilkinson
Co Director, Neuroscience and Mental Health Innovation Institute
- wilkinsonl@cardiff.ac.uk
- +44(0) 29 2068 8461